J 2020

Associations between high triglycerides and arterial stiffness in a population-based sample: Kardiovize Brno 2030 study

PAVLOVSKA, Iuliia, Šárka KUNZOVÁ, Juraj JAKUBÍK, Jana HRUŠKOVÁ, Mária SKLADANÁ et. al.

Základní údaje

Originální název

Associations between high triglycerides and arterial stiffness in a population-based sample: Kardiovize Brno 2030 study

Autoři

PAVLOVSKA, Iuliia (804 Ukrajina, garant, domácí), Šárka KUNZOVÁ (203 Česká republika), Juraj JAKUBÍK (703 Slovensko), Jana HRUŠKOVÁ (203 Česká republika), Mária SKLADANÁ (703 Slovensko), Irma Magaly RIVAS-SERNA, Jose R. MEDINA-INOJOSA, Francisco LOPEZ-JIMENEZ, Robert VYSOKÝ (203 Česká republika, domácí), Yonas E. GEDA, Gorazd B. STOKIN a Juan P. GONZALEZ-RIVAS

Vydání

LIPIDS IN HEALTH AND DISEASE, LONDON, BMC, 2020, 1476-511X

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30308 Nutrition, Dietetics

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 3.876

Kód RIV

RIV/00216224:14110/20:00116193

Organizační jednotka

Lékařská fakulta

UT WoS

000553306200001

Klíčová slova anglicky

Triglycerides; Vascular stiffness; Metabolic syndrome; Cardio-ankle vascular index; Atherosclerosis; Risk factors

Štítky

Příznaky

Mezinárodní význam
Změněno: 27. 5. 2021 08:53, Mgr. Tereza Miškechová

Anotace

V originále

Background The term arterial stiffness (ArSt) describes structural changes in arterial wall related to the loss of elasticity and is known as an independent predictor of cardiovascular diseases (CVD). The evidence relating to ArSt and triglycerides (TG) shows contradictory results. This paper means to survey the association between high TG and ArSt, utilizing the cardio-ankle vascular index (CAVI). Methods Subjects aged between 25 and 64 years from a random population-based sample were evaluated between 2013 and 2016. Data from questionnaires, blood pressure, anthropometric measures, and blood samples were collected and analyzed. CAVI was measured using VaSera VS-1500 N devise. Subjects with a history of CVD or chronic renal disease were excluded. Results One thousand nine hundred thirty-four participants, 44.7% of males, were included. The median age was 48 (Interquartile Range [IQR] 19) years, TG levels were 1.05 (0.793) mmol/L, and CAVI 7.24 (1.43) points. Prevalence of high CAVI was 10.0% (14.5% in males and 6.4% in females;P < 0.001) and prevalence of hypertriglyceridemia was 20.2% (29.2% in males and 13% in females,P < 0.001). The correlation between TG and CAVI was 0.136 (P < 0.001). High CAVI values were more prevalent among participants with metabolic syndrome (MetS), high blood pressure, dysglycemia, abdominal obesity, high LDL-cholesterol (LDL-c), and high total cholesterol. Using binary regression analysis, high TG were associated with high CAVI, even after adjustment for other MetS components, age, gender, smoking status, LDL-c, and statin treatment (beta = 0.474, OR = 1.607, 95% CI = 1.063-2.429,P = 0.024). Conclusion TG levels were correlated with ArSt, measured as CAVI. High TG was associated with high CAVI independent of multiple cardiometabolic risk factors. Awareness of the risks and targeted treatment of hypertriglyceridemia could further benefit in reducing the prevalence of CVD and events.